126 related articles for article (PubMed ID: 17569258)
1. [Cryosurgical ablation for aged patients with severe benign prostate hyperplasia: a report of 21 cases].
Wang AX; Wang D; Tong W
Zhonghua Nan Ke Xue; 2007 May; 13(5):421-3. PubMed ID: 17569258
[TBL] [Abstract][Full Text] [Related]
2. [Data analysis of the objective observation parameters of benign prostatic hyperplasia patients accepting different treatment regimens].
Zhang YG; Wang JY; Liu M; Wan B; Wei D; Deng SM; Xu J; Wu JY; Chu X; Zeng P
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1690-2. PubMed ID: 19024540
[TBL] [Abstract][Full Text] [Related]
3. Cryosurgery as a treatment for prostate carcinoma: results and complications.
Wong WS; Chinn DO; Chinn M; Chinn J; Tom WL; Tom WL
Cancer; 1997 Mar; 79(5):963-74. PubMed ID: 9041159
[TBL] [Abstract][Full Text] [Related]
4. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
Elmansy HM; Elzayat EA; Sampalis JS; Elhilali MM
Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
[TBL] [Abstract][Full Text] [Related]
5. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
Ruszat R; Seitz M; Wyler SF; Müller G; Rieken M; Bonkat G; Gasser TC; Reich O; Bachmann A
BJU Int; 2009 Sep; 104(6):820-5. PubMed ID: 19239441
[TBL] [Abstract][Full Text] [Related]
6. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
Xu J; Qian WQ; Song JD
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of prostatic-specific antigen levels in patients with benign prostatic hyperplasia complicated by low urinary tract syndrome].
Zhu YJ; Ye M; Wang WM; Shen HB; Chen JH; Chen F
Zhonghua Nan Ke Xue; 2006 Feb; 12(2):156-8. PubMed ID: 16519156
[TBL] [Abstract][Full Text] [Related]
8. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.
Polascik TJ; Nosnik I; Mayes JM; Mouraviev V
Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220
[TBL] [Abstract][Full Text] [Related]
9. [Cryosurgical ablation for 23 cases of prostate cancer guided by rectal ultrasound].
Wu Q; Wang XS; Qian JX; Zhang JX; Xu Q; Cao CW; Gu XQ; Luo YZ; Wang JJ
Zhonghua Nan Ke Xue; 2005 Sep; 11(9):670-3. PubMed ID: 16209207
[TBL] [Abstract][Full Text] [Related]
10. Relationship of prostate-specific antigen and prostate volume in Korean men with biopsy-proven benign prostatic hyperplasia.
Lee SE; Chung JS; Han BK; Moon KH; Hwang SI; Lee HJ; Choe G; Hong SK
Urology; 2008 Mar; 71(3):395-8. PubMed ID: 18342171
[TBL] [Abstract][Full Text] [Related]
11. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
[TBL] [Abstract][Full Text] [Related]
12. Laser ablation of prostatic hypertrophy.
Strauss BS
N J Med; 1995 Jul; 92(7):455-8. PubMed ID: 7544883
[TBL] [Abstract][Full Text] [Related]
13. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
Shao Q; Song J; Zhou ZJ; Du LD
Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
[TBL] [Abstract][Full Text] [Related]
14. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
15. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
Wu XJ; Yang LY; Zhang XZ
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
17. [Study on patients with benign prostate hyperplasia treated by the therapeutic regimen of watchful waiting during a twenty-four-month follow-up period].
Zhang YG; Wang JY; Liu M; Xu J; Wu JY; Xin Y; Wan B; Wei D; Zhu SC; Zeng P
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):611-3. PubMed ID: 19040049
[TBL] [Abstract][Full Text] [Related]
18. [Pre- and post-prostatectomy variation and supplement of sexual hormones in patients with benign prostatic hyperplasia].
Ren XM; Ying J; Yao DH; Jiang YQ; Xu MX
Zhonghua Nan Ke Xue; 2005 Jan; 11(1):50-2, 55. PubMed ID: 15704683
[TBL] [Abstract][Full Text] [Related]
19. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
[TBL] [Abstract][Full Text] [Related]
20. [Dissection of prostate coalesce in treatment of benign prostate hypertrophy with relatively small volume].
Qiu MX; Wang D; Wu HM; Xiong GB; Chen ZX
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1852-3. PubMed ID: 17922999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]